LD6 Stock Overview
Operates as a psychedelic research and development company. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Core One Labs Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.07 |
| 52 Week High | CA$0.33 |
| 52 Week Low | CA$0.025 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | -7.85% |
| 1 Year Change | -62.95% |
| 3 Year Change | -92.58% |
| 5 Year Change | -98.66% |
| Change since IPO | -98.53% |
Recent News & Updates
Recent updates
Shareholder Returns
| LD6 | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 0% | 2.3% | 1.4% |
| 1Y | -62.9% | -14.5% | 9.1% |
Return vs Industry: LD6 underperformed the German Pharmaceuticals industry which returned -12.7% over the past year.
Return vs Market: LD6 underperformed the German Market which returned 13.2% over the past year.
Price Volatility
| LD6 volatility | |
|---|---|
| LD6 Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 5.6% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.5% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: LD6's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: Insufficient data to determine LD6's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | n/a | Joe Shacker | core1labs.com |
Core One Labs Inc. operates as a psychedelic research and development company. The company focuses on providing psychedelic medicines to novel delivery systems and psychedelic assisted psychotherapy; and intends to further develop and apply the technology to psychedelic compounds, such as psilocybin. It also provides natural health products; news dissemination services; financing services; and operates medical clinics, as well as engages in micro cultivation.
Core One Labs Inc. Fundamentals Summary
| LD6 fundamental statistics | |
|---|---|
| Market cap | €4.52m |
| Earnings (TTM) | -€10.57m |
| Revenue (TTM) | €303.19k |
0.0x
P/S Ratio0.0x
P/E RatioIs LD6 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LD6 income statement (TTM) | |
|---|---|
| Revenue | CA$458.54k |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$458.54k |
| Other Expenses | CA$16.44m |
| Earnings | -CA$15.98m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did LD6 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/11/03 08:16 |
| End of Day Share Price | 2024/08/06 00:00 |
| Earnings | 2023/03/31 |
| Annual Earnings | 2023/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Core One Labs Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|